Firm / Organisation

Arnold & Porter

This content is provided by Arnold & Porter.

Chair: Richard Alexander
Co-Managing Partners: Anne Davis, Michael Daneker
Partner: Ian Dodds-Smith
Number of partners: 17
Assistant solicitors: 31
UK Total: 48
International Total: Nearly1,000

Competition & Litigation:
John Schmidt, Jane Wessel
Corporate & Securities: Anna Buscall, Andrew Harris, Sean Scanlon, Jeremy Willcocks
Commercial Dispute Resolution: Hilton Mervis
Employment: Henry Clinton-Davis
Finance: Stuart Axford, Colin Tan
Intellectual Property & Technology: Richard Dickinson
Investment Management: Simon Firth
International Arbitration: Dmitri Evseev, Patricio Grané Labat, David Reed
EU Life Sciences: Ian Dodds-Smith
Product Liability: Ian Dodds-Smith
UK Enforcement & Dispute Resolution: Kathleen Harris, Sean Curran
Telecommunications, Internet & Media: Rob Bratby

THE FIRM Arnold & Porter is a nearly 1,000 lawyer firm with renowned regulatory expertise, sophisticated litigation and transactional practitioners, and leading multidisciplinary practices in the life sciences and financial services industries. The London office, established in 1997, is home to the firm’s European regulatory and corporate and finance practices, and includes specialists in life sciences, intellectual property, telecoms, product liability, commercial litigation and arbitration, competition, white-collar crime, and employment. The office’s clients include large multinational companies, start-up businesses, banking institutions and financial services companies, and individuals.


Life Sciences:

One of the largest pharmaceutical and medical devices regulatory practices in the EU, dealing with all aspects of pre- and post-marketing authorisations and appeals, and on issues arising from emerging technologies such as gene, cell, tissue and pharmacogenomics. The practice has experience in advising on all types of collaborative and licensing agreements, and corporate transactions for pharmaceutical and biotech companies, offering an unparalleled integration of regulatory, intellectual property, and competition law expertise.

Intellectual Property & Technology:
In-depth experience in many aspects of IP, including licensing, rights acquisition, brand co-existence, delimitation, data privacy, brand-sharing agreements and commercial contracts (including patents, trademarks, designs and copyright), as well as high value technology related litigation, including government contract disputes and software licensing matters.

Telecommunications, Internet & Media:
Advises UK, European and North American telecommunications operators, service providers and ISPs on regulatory and commercial issues. It is consulted frequently by regulatory authorities and financial institutions on regulatory issues affecting the telecommunications sector. Additionally, the practice advises clients on matters relating to data protection, cyber security, emerging new technology and new media issues.

Product Liability:
The large team of specialist lawyers, many dual-qualified in law and medicine, is experienced in conducting the defence of unitary and group product liability proceedings relating to medicines, medical devices, foods, pesticides, and other chemical products.

Commercial Dispute Resolution:
Deep experience in handling large-scale international commercial litigation including shareholder, joint venture, partnership disputes, banking litigation, complex civil fraud cases, competition High Court related cases, corporate reputation and regulatory investigations.

Advises on both EU and UK competition law issues. It represents clients from a broad range of industries before the UK Office of Fair Trading and the Competition Commission in relation to competition concerns, including merger control and allegations of abuse of dominant position or anti-competitive practices. The practice handles major litigation, antitrust inquiries and audits, price-fixing issues, distribution and licensing agreements, strategic alliances, and joint ventures.

Advises public and private companies on domestic and cross-border M&A, joint ventures, strategic alliances, flotations/IPOs, public takeovers, shareholder disputes, private equity transactions and venture capital financings. It also advises on public and private offerings of debt and equity securities both for issuers and underwriters.

Represents arrangers, issuers, investors and servicers in a range of securitisation transactions. The practice also advises financial institutions and their counterparties in relation to derivatives transactions. The practice also advises on syndicated and leveraged finance.

Investment Management:
Advises on the structuring, formation, promotion, regulation and operation of closed and open-ended investment funds.

UK Enforcement & Dispute Resolution:
Advises corporates on how to handle investigations in relation to potential economic crime offences with an increasing focus on matters relating to FCPA, anti-bribery and money laundering compliance, together with economic crime defence, self-reporting and negotiations with law enforcement agencies, both in the UK and US, internal investigations for client organisations and external law enforcement investigations.

Covers all areas of employment and business immigration. It also handles the employment aspects of mergers and outsourcing as well as TUPE.

International Arbitration:
The International Arbitration Group represent dozens of Sovereign States, state-owned companies and entities, corporations and individuals in Investor-State and commercial arbitrations before international arbitral institutions worldwide, and under a variety of arbitral rules, including ICSID, UNCITRAL, ICC, LCIA, AAA/ICDR, and various chambers of commerce and industry-specific institutions. The group has extensive experience arbitrating disputes in a range of industries and economic sectors, including energy, mining, construction, intellectual property licensing, telecommunications, banking, finance, and government concessions.


Total 3 contributions

Life Sciences 2020 Law and Practice in USA

Daniel A. Kracov, David R. Marsh, Vinita Kailasanath, Alice Ho

Read now
Life Sciences 2020 Law and Practice in UK

Jackie Mulryne, Ewan Townsend, Dr Lincoln Tsang, Dr Adela Williams

Read now
International Arbitration 2019 Trends and Developments in USA

Maria Chedid, Kabir Duggal, Katelyn Horne, Caroline Kelly

Read now